Aortography and peripheral angiography
J9 · Effective Oct 31, 2016
164 active Medicare policies list C71.0, and 27 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
Showing 100 of 164
J9 · Effective Oct 31, 2016
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
27 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 22 · All Aetna policies
| Policy | Effective | Status of C71.0 |
|---|---|---|
| Bevacizumab for Non-Ocular Indications | Feb 20, 2024 | Covered |
| Brachytherapy | Jun 6, 2023 | Covered |
| Cerebral Perfusion Studies | Sep 14, 2023 | Covered |
| Constraint-Induced Therapy | Sep 14, 2023 | Covered |
| Deep Brain Stimulation | Apr 11, 2023 | Covered |
| Flow Cytometry, Ektacytometry, DNA Ploidy, and S-phase Fraction | Jun 5, 2023 |
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Jul 15, 2026
JK · Effective Jul 15, 2026
JJ · Effective Jul 24, 2022
JM · Effective Jul 24, 2022
J15 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Aug 21, 2022
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Oct 5, 2015
JE · Effective Apr 15, 2016
JF · Effective Apr 15, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Jul 17, 2017
J8 · Effective Jul 17, 2017
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Feb 10, 2020
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J15 · Effective Jul 27, 2020
JE · Effective Dec 26, 2022
JF · Effective Dec 26, 2022
JJ · Effective Feb 3, 2020
JM · Effective Feb 3, 2020
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J9 · Effective Oct 1, 2015
J6 · Effective May 1, 2017
JK · Effective May 1, 2017
J9 · Effective Oct 1, 2015
J15 · Effective Oct 24, 2016
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Dec 3, 2023
JM · Effective Dec 3, 2023
JJ · Effective Nov 12, 2023
JM · Effective Nov 12, 2023
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
| In Vivo Analysis of Gastro-Intestinal and Urothelial Lesions | Oct 17, 2023 | Covered |
|---|
| Intraoperative Neurophysiological Monitoring | Oct 26, 2023 | Covered |
|---|
| Magnetic Resonance Angiography (MRA) and Magnetic Resonance Venography (MRV) | Mar 23, 2023 | Covered |
|---|
| Magnetic Resonance Spectroscopy (MRS) | Apr 11, 2023 | Covered |
|---|
| Policy | Effective | Status of C71.0 |
|---|---|---|
| Cryosurgical, Radiofrequency, Microwave or Laser Ablation to Treat Solid Tumors Outside the Liver | Oct 1, 2026 | Covered |
| Electric Tumor Treatment Field (TTF) Therapy | Jul 1, 2026 | Covered |
| Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors | Jan 6, 2026 | Covered |
| Policy | Effective | Status of C71.0 |
|---|---|---|
| Visual Field Testing | Not recorded | Covered |
| Policy | Effective | Status of C71.0 |
|---|---|---|
| Botulinum Toxins A and B | Jan 1, 2026 | Covered |